AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.030
+0.010 (0.50%)
At close: May 16, 2025, 4:00 PM
2.010
-0.020 (-0.99%)
After-hours: May 16, 2025, 7:45 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $604.91 million as of May 16, 2025. Its market cap has decreased by -45.55% in one year.
Market Cap
604.91M
Enterprise Value
62.86M
1-Year Change
-45.55%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $604.91M, a decrease of -96.14%. That is a compound annual growth rate of -52.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 601.94M | -30.45% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.10B |
| Johnson & Johnson | 363.65B |
| AbbVie | 323.34B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 261.62B |
| Abbott Laboratories | 234.33B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |